Effect of corticosteroid therapy in acute pain edema caused by Herpes Zoster
Purpose: To evaluate the curative effect of corticosteroids in the treatment of acute pain, local edema, and skin lesions caused by herpes zoster, and to develop some pertinent therapeutic guidelines.
Methods: A total of 48 cases of patients diagnosed with herpes zoster from 2010 to 2011 in the dermatology clinic of Shan Dong Traffic Hospital were selected and all received the same therapy of antiviral, pain-relieving and nerve nutrition. They were divided into a corticosteroid application group, with 24 patients treated with corticosteroids, and a control group of 24 patients without corticosteroids. Local swelling subsided in the corticosteroid group. The differences observed in pain relief and days needed for blisters to dry and scab between the two patient groups were analyzed to determine significance and, thus, assess the curative effect of corticosteroids in treatment of herpes zoster.
Results: Patients in the glucocorticosteroid application group relieved pain faster than patients in the control group (2.38 ± 1.41 days vs 5.50 ± 3.19 days), and the difference was significant (p < 0.05). Skin lesions of patients in the glucocorticosteroid application group healed quicker than that of patients in control group (2.83 ± 0.87 days vs 3.54 ± 1.02 days), and the difference was remarkable (p < 0.05). Local swelling of patients in the glucocorticosteroid application group recovered rapidly after treatment. .
Conclusion: Treatment of herpes zoster with appropriate corticosteroid isodose application can effectively relieve acute pain and local swelling, and speed up scabbing and healing of skin lesions.
Keywords: Herpes zoster, Corticosteroids, Local edema, Scab, Skin lesions, Acute pain, Blisters, Therapeutic guidelines
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.